In its budget request for the year starting July 1, 2026, the state Executive Office of Health and Services said GLP-1 expenses for weight loss in the Medicaid program rose 400% in the two years that ended June 30 and are projected to rise somewhere between 120% and 200% by June 30, 2028
The maximum dose in a single day or infusion is usually around 500-1,000 mg in clinical research settings
New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions Issues like pancreatitis, stomach paralysis higher among patients using GLP-1 inhibitor medications Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, according to a study published on Thursday
Each injection provides valuable support for a range of individuals dealing with fatigue or those managing specific health or nutritional challenges
Early concerns that GLP-1 medications might worsen kidney function have not been supported by long term data
- Rice extracts & ceramide complex: Strengthen the skin barrier & make the skin supple